These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 17620746

  • 1. Combining prevention, treatment and care: lessons from South Africa.
    Achmat Z, Simcock J.
    AIDS; 2007 Jul; 21 Suppl 4():S11-20. PubMed ID: 17620746
    [Abstract] [Full Text] [Related]

  • 2. The economics of effective AIDS treatment in Thailand.
    Over M, Revenga A, Masaki E, Peerapatanapokin W, Gold J, Tangcharoensathien V, Thanprasertsuk S.
    AIDS; 2007 Jul; 21 Suppl 4():S105-16. PubMed ID: 17620745
    [Abstract] [Full Text] [Related]

  • 3. HIV/AIDS situation in Africa.
    Ogunbodede EO.
    Int Dent J; 2004 Dec; 54(6 Suppl 1):352-60. PubMed ID: 15631096
    [Abstract] [Full Text] [Related]

  • 4. Strategies to optimize HIV treatment outcomes in resource-limited settings.
    Nakanjako D, Colebunders R, Coutinho AG, Kamya MR.
    AIDS Rev; 2009 Dec; 11(4):179-89. PubMed ID: 19940945
    [Abstract] [Full Text] [Related]

  • 5. Economic impact of HIV.
    Veenstra N, Whiteside A.
    Best Pract Res Clin Obstet Gynaecol; 2005 Apr; 19(2):197-210. PubMed ID: 15778110
    [Abstract] [Full Text] [Related]

  • 6. Provision of antiretroviral therapy in South Africa: unique challenges and remaining obstacles.
    Ojikutu B, Jack C, Ramjee G.
    J Infect Dis; 2007 Dec 01; 196 Suppl 3():S523-7. PubMed ID: 18181705
    [Abstract] [Full Text] [Related]

  • 7. Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy.
    Reid SE, Reid CA, Vermund SH.
    Int J STD AIDS; 2004 Nov 01; 15(11):713-6. PubMed ID: 15537453
    [Abstract] [Full Text] [Related]

  • 8. Research as a path to wide-scale implementation of antiretroviral therapy in Africa.
    Sanne I, van der Horst C.
    J HIV Ther; 2004 Sep 01; 9(3):65-8. PubMed ID: 15534564
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Vaginal microbicides save money: a model of cost-effectiveness in South Africa and the USA.
    Verguet S, Walsh JA.
    Sex Transm Infect; 2010 Jun 01; 86(3):212-6. PubMed ID: 20522634
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa.
    Wood E, Braitstein P, Montaner JS, Schechter MT, Tyndall MW, O'Shaughnessy MV, Hogg RS.
    Lancet; 2000 Jun 17; 355(9221):2095-100. PubMed ID: 10902622
    [Abstract] [Full Text] [Related]

  • 15. The private sector and HIV/AIDS in Africa: taking stock of 6 years of applied research.
    Rosen S, Feeley F, Connelly P, Simon J.
    AIDS; 2007 Jul 17; 21 Suppl 3():S41-51. PubMed ID: 17666961
    [Abstract] [Full Text] [Related]

  • 16. 'Time is costly': modelling the macroeconomic impact of scaling-up antiretroviral treatment in sub-Saharan Africa.
    Ventelou B, Moatti JP, Videau Y, Kazatchkine M.
    AIDS; 2008 Jan 02; 22(1):107-13. PubMed ID: 18090398
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The costs and benefits of private sector provision of treatment to HIV-infected employees in Kampala, Uganda.
    Marseille E, Saba J, Muyingo S, Kahn JG.
    AIDS; 2006 Apr 04; 20(6):907-14. PubMed ID: 16549976
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.